<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04593225</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)490/2020</org_study_id>
    <nct_id>NCT04593225</nct_id>
  </id_info>
  <brief_title>Effectiveness of VIRTUAL SFCAMINA STUDY</brief_title>
  <acronym>SFCAMINA</acronym>
  <official_title>Effectiveness of Virtual Multicomponent Treatment for Chronic Fatigue Syndrome: VIRTUAL SFCAMINA STUDY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to analyse the effectiveness of the VIRTUAL SFCAMINA&#xD;
      multicomponent treatment program as coadjuvant of treatmentas- usual (TAU) compared to TAU&#xD;
      alone. In this Randomized Controlled Trial (RCT), in addition to evaluating the clinical&#xD;
      effects of VIRTUAL SFCAMINA treatment in the short- and long term.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a tree-arm RCT focused on the safety and potential effectiveness of the&#xD;
      multicomponent program VIRTUAL SFCAMINA as coadjuvant of treatmentas- usual (TAU) vs. TAU&#xD;
      alone and on the comparation of the physiotherapy part of the multicomponent program.&#xD;
&#xD;
        -  VIRTUAL SFCAMINA combines multicomponent approach based on Pain Neuroscience Education&#xD;
           (PNE), therapeutic exercise, Cognitive Behavioural Therapy (CBT) and Mindfulness&#xD;
           training.&#xD;
&#xD;
        -  Physiotherapy part of VIRTUAL SFCAMINA combines multicomponent approach based on Pain&#xD;
           Neuroscience Education (PNE) and therapeutic exercise.&#xD;
&#xD;
        -  The main hypothesis is that improvement on fatigue of patients with fibromyalgia can be&#xD;
           achieved by the direct intervention on mechanisms such as kinesiophobia, fear avoidance&#xD;
           and by individualized therapeutic exercise.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">April 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment Single-blind, parallel-group, randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Multidimensional Fatigue Inventory (MFI)</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Multidimensional Fatigue Inventory (MFI), a 20-item instrument consisting of several subscales including general fatigue and reduced activity. Severe fatigue it is defined as a score of greater than or equal to 13 on the MFI general fatigue subscale or greater than or equal to 10 on the MFI reduced activity subscale. The mean MFI general fatigue scores ranged from 18.3 to 18.8</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tampa Scale for Kinesiophobia (TSK-11)</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>TSK-11 is used to assess fear of pain and movement. It consists of 11 items, which are answered on a Likert scale of 4 points. Total scores of each scale range from 11 to 44, where higher scores indicate a greater fear of pain and movement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>HADS is used to quantify the severity of anxiety and depression symptoms. It consists of two dimensions (anxiety and depression) of 7 items each responding on a Likert scale of 4 points. Total scores of each scale (HADS-A and HADSD) range from 0 to 21, where higher scores indicate greater severity of symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Function of the 36-Item Short Form Survey (SF-36)</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Physical Function of the 36-Item Short Form Survey (SF-36) was used to measure physical function.This dimension comprises a total of 10 items, which are answered on a Likert scale of 3 points. Total scores on each scale are then transformed and can range from 0 to 100, with higher scores indicate better physical function.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Chronic Fatigue Syndrome</condition>
  <arm_group>
    <arm_group_label>TAU + multicomponent treatment VIRTUAL SFCAMINA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VIRTUAL SFCAMINA is a multicomponent non-pharmacological program based on Pain Neuroscience Education (PNE), therapeutic exercise, Cognitive Behavioural Therapy (CBT) and Mindfulness Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as Usual (TAU)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment-as-Usual (TAU) consisted of the prescribed drugs adapted to the symptomatic profile of each patient and basic face to face and written advice on PNE and aerobic exercise adapted to the physical capacities of the patients at the beginning of the study.patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physiotherapy part of VIRTUA SFCAMINA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The physiotherapy part of the VIRTUAL SFCAMINA is a multicomponent non-pharmacological program based on Pain Neuroscience Education (PNE) and therapeutic exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TAU + multicomponent treatment VIRTUAL SFCAMINA</intervention_name>
    <description>Group treatment protocol of 12 weekly 60 minute virtual sessions. All sessions include the following ingredients (approx. in the same order): - Pain neuroscience education (15 min.) - Cognitive restructuring (15 min.) - Mindfulness techniques (15 min.) - Physical exercise(15 min.) - Treatment as Usual (TAU) Standard pharmacological treatment usually provided to patients with SFC.</description>
    <arm_group_label>TAU + multicomponent treatment VIRTUAL SFCAMINA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Treatment as Usual (TAU)</intervention_name>
    <description>Treatment-as-Usual (TAU) consisted of the prescribed drugs adapted to the symptomatic profile of each patient and basic face to face and written advice on PNE and aerobic exercise adapted to the physical capacities of the patients at the beginning of the study.</description>
    <arm_group_label>Treatment as Usual (TAU)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TAU + Physiotherapy part of VIRTUAL FIBROWALK</intervention_name>
    <description>Group treatment protocol of 12 weekly 60 minute virtual sessions. All sessions include the following ingredients: - Pain neuroscience education (30 min.)&#xD;
- Physical exercise(30 min.) - Treatment as Usual (TAU). Standard pharmacological treatment usually provided to patients with SFC.</description>
    <arm_group_label>Physiotherapy part of VIRTUA SFCAMINA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meet the Fukuda and Holmes classification criteria for Fatigue Syndrome Chronicle&#xD;
&#xD;
          -  Age equal to or greater than 18 years&#xD;
&#xD;
          -  Understand and agree to participate in the study&#xD;
&#xD;
          -  Sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Terminal clinical conditions or scheduled treatments that may interrupt the study&#xD;
             follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mayte Serrat, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vall d'Hebr√≥n Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mayte Serrat, MSc</last_name>
    <phone>+34934893891</phone>
    <phone_ext>6644</phone_ext>
    <email>mserrat@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elena Granell</last_name>
    <phone>+34934893891</phone>
    <email>elena.granell@vhir.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vall d'Hebr√≥n Hospital</name>
      <address>
        <city>Barcelona</city>
        <zip>08023</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mayte Serrat, MSc</last_name>
      <phone>+34934893891</phone>
      <phone_ext>6644</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vall d'Hebr√≥n Hospital</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mayte Serrat, MSc</last_name>
      <phone>+34934893891</phone>
      <phone_ext>6644</phone_ext>
      <email>mserrat@vhebron.net</email>
    </contact>
    <contact_backup>
      <last_name>Elena Granell</last_name>
      <phone>+34934893891</phone>
      <email>elena.granell@vhir.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>multicomponent treatment</keyword>
  <keyword>Chronic Fatigue Syndrome</keyword>
  <keyword>pain neuroscience education</keyword>
  <keyword>therapeutic exercise</keyword>
  <keyword>cognitive behavioural therapy</keyword>
  <keyword>mindfulness</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

